Silo Wellness CEO Douglas K. Gordon tells Psychedelic Spotlight that this is a “crucial” step toward “the mainstream acceptance of psychedelics and overall de-stigmatization of mushrooms, by way of the functional category.”
This week in psychedelic business news: More psychedelic clinical trials are green-lighted, new partnerships inked, and Beckley Psytech successfully completes upsized Series B financing.
The Bob Marley-inspired line of psychedelic and functional mushrooms, Marley One, has officially launched through partner Silo Wellness.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.